[et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” background_enable_color=”off” background_image=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/01\/numbers-bg.jpg” parallax=”on” custom_padding=”110px||110px||true|false” saved_tabs=”all” global_colors_info=”{}”][et_pb_row custom_padding_last_edited=”on|phone” _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”60px||||false|false” custom_padding_tablet=”60px||||false|false” custom_padding_phone=”60px||||false|false” animation_style=”slide” animation_direction=”top” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title meta=”off” featured_image=”off” _builder_version=”4.27.4″ _module_preset=”default” title_font=”|||on|||||” title_text_align=”center” title_text_color=”#FFFFFF” global_colors_info=”{}”][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”||||false|false” custom_padding=”165px||||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” animation_style=”slide” animation_direction=”left” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/02\/Cons.png” title_text=”Cons” align=”center” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”|700|||||||” text_text_color=”#b5c2ce” text_letter_spacing=”1px” text_line_height=”1.4em” text_orientation=”center” custom_padding=”15px||||false|false” global_colors_info=”{}”]<\/p>\n
The Curriculum Development of Human Clinical Trials for the Next Generation Biomedical Students
Developing educational materials related to human clinical trials for biomedical students<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_orientation=”center” global_colors_info=”{}”]<\/p>\n
The CONSCIOUS project was developed within the ERASMUS+ programme under the leadership of the University of P\u00e9cs and in cooperation with Masaryk University, University College Cork (Ireland), University Nova de Lisboa (Portugal) and University of Paris (France); ECRIN was an associate partner of the project. The subject of the CONSCIOUS project was the development of curricula<\/strong> and e-learning materials for undergraduate biomedical students<\/strong>, with the intention of bridging gaps in the professional curriculum covering the field of clinical studies<\/strong>. The project was successfully completed in 2021. <\/p>\n The CONSCIOUS project has developed 14 e-learning lessons covering the basic knowledge and skills important for understanding and conducting clinical trials.<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” animation_style=”slide” animation_direction=”left” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” animation_style=”slide” animation_direction=”left” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” header_3_text_align=”left” header_3_font_size=”30px” header_4_text_align=”center” header_3_text_align_tablet=”center” header_3_text_align_phone=”center” header_3_text_align_last_edited=”on|tablet” header_3_font_size_tablet=”24px” header_3_font_size_phone=”24px” header_3_font_size_last_edited=”on|tablet” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][et_pb_divider color=”#1C203A” divider_weight=”3px” _builder_version=”4.27.4″ _module_preset=”default” max_width=”40px” max_width_tablet=”40px” max_width_phone=”40px” max_width_last_edited=”on|desktop” module_alignment=”left” custom_margin=”-10px||||false|false” module_alignment_tablet=”center” module_alignment_phone=”center” module_alignment_last_edited=”on|tablet” locked=”off” global_colors_info=”{}”][\/et_pb_divider][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_orientation_tablet=”” text_orientation_phone=”” text_orientation_last_edited=”on|tablet” global_colors_info=”{}”]<\/p>\n <\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”0px||||false|false” animation_style=”slide” animation_direction=”left” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_button button_url=”http:\/\/conscious.novaims.unl.pt\/” url_new_window=”on” button_text=”Access to lessons*” button_alignment=”center” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_use_icon=”off” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][\/et_pb_button][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”|700|||||||” text_text_color=”#b5c2ce” text_letter_spacing=”1px” text_line_height=”1.4em” custom_padding=”15px||||false|false” global_colors_info=”{}”]<\/p>\n * <\/span>All materials are available free of charge <\/strong> within the learning platform. To access the learning platform, simply request one of the authorized persons listed on the project homepage to generate access credentials <\/strong>. The platform extends each chapter with interactive elements and practical examples for knowledge application. In addition to the e-learning materials, teacher’s manuals have been developed to provide support to lecturers who decide to use the e-learning materials in lecturer-led teaching. <\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” background_color=”#F2F8FF” custom_margin=”|150px||150px|false|true” custom_margin_tablet=”|20px||20px|false|true” custom_margin_phone=”|20px||20px|false|true” custom_margin_last_edited=”on|phone” border_radii=”on|20px|20px|20px|20px” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_orientation_tablet=”center” text_orientation_phone=”center” text_orientation_last_edited=”on|tablet” global_colors_info=”{}”]<\/p>\n Project code:<\/strong> 2018-1-HU01-KA203-047811<\/p>\n Solution period:<\/strong> 1\/2019 – 8\/2021 (extended to 10\/21)<\/p>\n European Union – Erasmus+ Key Action 2: Cooperation on innovation and exchange of best practices; Strategic partnerships in education, training and youth<\/p>\n Faculty \/ Department of MU:<\/strong> Faculty of Medicine<\/p>\n Principal investigator of the project:<\/strong> doc. MUDr. Regina Demlov\u00e1, Ph.D. <\/p>\n Cooperating organisations:<\/strong><\/p>\nTopics of e-learning lessons:<\/h3>\n
\n\n
\n 1. What is a clinical trial?<\/strong>
(What is a Clinical Trial?)<\/em><\/td>\n<\/tr>\n\n 2. Why are clinical trials the gold standard?<\/strong>
(Why are clinical trials the gold standard?)<\/em><\/td>\n<\/tr>\n\n 3. Case Study: Tuskegee Syphilis<\/strong>
(Case Study: Tuskegee Syphilis)<\/em><\/td>\n<\/tr>\n\n 4. Ethics in clinical trials<\/strong>
(Ethics in Clinical Trials)<\/em><\/td>\n<\/tr>\n\n 5. What patients should know – informed consent<\/strong>
(What patients should know – informed consent)<\/em><\/td>\n<\/tr>\n\n 6. Formulating the research question and defining the research objective<\/strong>
(Equipoise; Forming a research question and defining the outcome)<\/em><\/td>\n<\/tr>\n\n Phase 7 of the clinical trial<\/strong>
(Clinical trial phases)<\/em><\/td>\n<\/tr>\n\n 8. Phase 3 study designs <\/strong>
(Phase 3 Trial Design)<\/em><\/td>\n<\/tr>\n\n 9. Clinical Trial Protocol and Case Report Form<\/strong>
(Clinical Trial Protocol & Case Report Form)<\/em><\/td>\n<\/tr>\n\n 10. Numbers… sample size and why it is important; interpretation of results<\/strong>
(The numbers… sample size, why it is important, interpreting the results)<\/em><\/td>\n<\/tr>\n\n 11. Medical devices and advanced therapies<\/strong>
(Medical Devices and Advanced Therapies)<\/em><\/td>\n<\/tr>\n\n 12. Clinical Trial Management<\/strong>
(Trial Management)<\/em><\/td>\n<\/tr>\n\n 13. Adverse events and reporting obligations<\/strong>
(Adverse events and reporting responsibilities)<\/em><\/td>\n<\/tr>\n\n 14. Critical appraisal of a randomized clinical trial, or “How to read an article”<\/strong>
(Critical appraisal of a randomized clinical trial – “How to read a paper”)<\/em><\/td>\n<\/tr>\n\n <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n